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Introduction 
 
 
Metallome is a newly coined term that means the entirety of metal and metalloid species within a 
cell or tissue type. The determination of metallomes requires analytical techniques that can provide 
qualitative and quantitative information of metal species. This concept has been named speciation, and the 
acquisition of data according to this concept is performed with hyphenated techniques involving both 
separation and detection methods. 
 Hyphenated techniques for metallome analysis consist of two independent analytical methods, 
i.e., a specific detection method for biometals and biometalloids, and a separation method based on the 
physical and chemical properties of biomolecules containing metals and metalloids. High-performance 
liquid chromatography (HPLC) is the most popular among the many techniques used for speciation such as 
gas chromatography, gel electrophoresis and capillary electrophoresis. Indeed, HPLC has several 
advantages over other separation techniques: the separation conditions are relatively similar to the 
physiological conditions, and diverse methods such as gel filtration, ion exchange, affinity and reversed 
phase are easily selectable. On the other hand, inductively coupled plasma–mass spectrometry (ICP-MS) 
has enabled multi-elemental detection with extremely high sensitivity and the discrimination of isotopes. 
Therefore, the coupling of HPLC with ICP-MS has been most widely used for speciation. 
 The speciation analyses of such biological samples as blood plasma, tissue extract and urine 
using conventional HPLC require relatively large volumes of sample at the µL level. However, the volumes 
of samples including extracts of gene-modified cells, digested spots from two-dimensional (2D) 
electrophoresis and tissue biopsy extracts are limited in recent metallome research. Thus, an analytical 
technique for samples having ultrasmall volumes, i.e., a micro/capillary HPLC-ICP-MS, is needed in place 
of conventional HPLC. Although most of the commercially available micro/capillary columns are reversed 
phase ones, the gel filtration column has gained increasing popularity because it possesses many 
advantages for the separation of biomolecules, as follows: it can be used for biological fluids that have not 
been subjected to any pretreatment, such as tissue supernatant, the elution conditions are similar to 
physiological conditions, i.e., elution is normally performed with a salt-containing solution, and the gel 
filtration column can be used for biomacromolecules of various sizes, such as proteins and nucleic acids. 
Indeed, the applicability of a micro gel filtration HPLC-ICP-MS system was shown in the speciation of 
selenocompounds in biological fluids. On the other hand, micro-sized ion-exchange columns are also 
required for the separation of biomolecules. In particular, 2D micro HPLC (gel filtration plus ion exchange) 
may provide novel information for the speciation of metallomes. However, optimization of the interface 
between the micro/capillary HPLC and ICP-MS is needed. 
 Metallothionein (MT) is a cysteine-rich low molecular weight protein. Mammals have at least 
four MT isoforms locating on an identical chromosome. Two of them are ubiquitously expressed in all 
tissues and cell types, and are called classical MTs, i.e., MT-I and MT-II. The primary structures of these 
two MTs are highly homologous with each other. Although an immunological assay using antibody raised 
against each classical MT isoform has been reported, analytical techniques using the antibodies are not 
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common because of difficulty of preparation. Therefore, anion-exchange HPLC, which separates MT-I and 
MT-II based on their isoelectric points, is the method of choice. The biological roles of these MT isoforms 
are proposed as follows: detoxification of metals including non-essential and excess essential metals, 
storage of essential metals, sequestration of reactive oxygen and nitrogen species (ROS and RNS, 
respectively) and electrophiles, and intracellular trafficking of zinc (Zn). Although it is known that these 
MT isoforms behave differently in chemical reactions such as oxidative degradation, it is not known 
whether there are any differences in the biological roles mentioned above between the two isoforms. Two 
strains of MT knockout mouse are available, but both MT-I and MT-II are simultaneously knocked out in 
those strains. Thus, they are inappropriate for use in the investigation of the differences in the biological 
function of classical MTs.  
Copper (Cu) is an essential trace element in living organisms. It functions as the active center of 
cuproenzymes, such as cytochrome c oxidase (CCO), Cu,Zn-superoxide dismutase (Cu,Zn-SOD, SOD1), 
ceruloplasmin, lysyl oxidase, tyrosinase, and dopamine β-hydroxylase. The mechanisms underlying Cu 
homeostasis are suggested as follows. Cu is mainly incorporated into cells as a monovalent Cu ion, i.e., 
cuprous ion, by Ctr1, a transporter expressed on the plasma membrane. Incorporated Cu associates with 
one of three cytoplasmic Cu escort proteins, the so-called Cu chaperones, for it to be escorted to specific 
organelles or cuproenzymes. Atox1, a Cu chaperone for the Golgi apparatus, hands over Cu to Atp7a and 
Atp7b, which are ATP-dependent Cu transporters into the secretory pathway of Cu via the Golgi apparatus. 
In the Golgi apparatus, Cu is incorporated into cuproenzymes, such as ceruloplasmin and lysyl oxidase, due 
to the secretion of these cuproenzymes into extracellular fluid. Otherwise, Cu is directly excreted from cells 
by secretory vesicles that translocate to the plasma membrane to exocytose Cu. Cox17, a Cu chaperone for 
the mitochondria, is required to donate Cu to CCO and/or SCO1, which is a recipient protein of Cu on the 
mitochondrial membrane. CCS, a Cu chaperone for SOD1, transports Cu to SOD1 in cytosol by forming a 
heterodimer with SOD1. In addition to these Cu chaperones, a novel Cu-regulating protein, Commd1, was 
recently characterized. It does not have apparent Cu-binding motifs in its molecule but is proposed to 
participate in the Cu efflux pathway by interacting with Atp7b. Indeed, Bedlington terriers demonstrated 
inherited hepatic Cu toxicosis due to a defect in Commd1. MT is suggested to be also a Cu-regulating 
protein. It actually binds Cu via Cu-thiolate clusters. Since MT binding of Cu is thermodynamically and 
kinetically stable, excess Cu is sequestered by MT to mask Cu toxicity. On the other hand, an alleviative 
role of MT in Cu deficiency was also suggested. Thus, MT may play a dual role in Cu homeostasis in 
mammalian cells. 
As mentioned above, Cu is regulated by various proteins, such as transporters across the 
membrane, chaperones in the cytoplasm, and MT that buffers Cu availability in cells. However, this rigid 
regulation may prevent us from experimentally disturbing intracellular Cu concentration and further 
analyzing the mechanisms of Cu regulation. In particular, MT is induced by either an excess or a deficiency 
of Cu to maintain Cu homeostasis. In some cases, it was suggested that MT did not contribute to the 
detoxification of Cu. For instance, it is reported that Formosan squirrels abnormally and inheritably 
accumulated Cu in the liver. Although other inherited Cu toxicosis animals, such as toxic milk mice and 
Long-Evans Cinnamon (LEC) rats, accumulated Cu in the form bound to MT in their livers, it was shown 
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that Cu accumulated in the liver of Formosan squirrels dominantly existed in the insoluble fraction of the 
liver and only a small amount was bound to MT. Alternatively, Cu that was rapidly administered to rats also 
existed in the form that was not bound to MT. However, these animals did not manifest Cu toxicity and thus, 
a detoxification mechanism that functions independently of MT is speculated. 
In this study, Chapter 1, I developed a 2D micro HPLC-ICP-MS system equipped with a gel 
filtration column and an anion-exchange column in a capillary size to separate two MT isoforms. To 
enhance the sensitivity of ICP-MS for the detection of the metal bound to MT, a low-volume spray 
chamber with sheath flow was newly designed and an enriched stable isotope was used. Further, MT-I and 
MT-II genes were specifically knocked down with the siRNA technique, and the effects of the siRNAs 
were evaluated using the 2D micro HPLC-ICP-MS system. In Chapter 2, HPLC-ICP-MS equipped with a 
narrow bore gel filtration column was developed to analyze the minute amount of tissue extract, and then 
the relevance between the amount of Cu in the form bound to MT (Cu-MT) and the expression of MT 
mRNA was evaluated to reveal the Cu metabolism in the mutant animal model. In Chapter 3, I intended to 
establish an experimental model in which Cu concentration was modified by gene knockdown (KD) in a 
Cu-regulating protein, and to show that the contribution of MT to Cu homeostasis could be ignored. In this 
regard, fibroblasts established from an MT-null mutant mouse, i.e., MT-knockout cells (MT-KO) cells, are 
frail against the Cu toxicity, and those cells are more useful to reveal Cu homeostasis than MT-wild type 
(MT-WT) cells. Atox1 KD was introduced into MT-KO cells. 
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Chapter 1 
 
 
Separation of metallothionein isoforms extracted 
from isoform-specif ic  knockdown cel l s  on 
two-dimensional micro high-performance liquid 
chromatography hyphenated with inductively  
coupled plasma-mass spectrometry 
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Abstract 
 
 
A two-dimensional (2D) micro HPLC-inductively coupled plasma mass spectrometry (ICP-MS) 
system consisting of a gel filtration column and an anion-exchange column was constructed to separate two 
metallothionein (MT) isoforms. To enhance the sensitivity of ICP-MS for the detection of the metal bound 
to MT, a low-volume spray chamber with sheath flow was newly designed and an enriched stable isotope 
was used. Two MT isoforms in a 100-nL portion of the sample prepared from cultured cells were separated 
and detected using the 2D micro HPLC-ICP-MS system. Moreover, MT-I and MT-II genes were 
specifically knocked down with the RNA interference (RNAi) technique, and the effects of the knockdown 
were evaluated by the reverse transcription-polymerase chain reaction (RT-PCR) and the 2D micro 
HPLC-ICP-MS system. The minimum cell number required by our 2D micro HPLC-ICP-MS system was 
calculated to be 2.0 x 103. As far as we know, this is the first report of the combination of nano-speciation 
(speciation of a sample at nanoliter level) and the RNAi technique. The techniques shown in this study are 
expected to contribute to clarifying the physiological and/or biological roles of MT isoforms. 
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Introduction 
 
 
Metallome is a newly coined term that means the entirety of metal and metalloid species within a 
cell or tissue type1. The determination of metallomes requires analytical techniques that can provide 
qualitative and quantitative information of metal species2,3. This concept has been named speciation, and 
the acquisition of data according to this concept is performed with hyphenated techniques involving both 
separation and detection methods4. 
 Hyphenated techniques for metallome analysis consist of two independent analytical methods, 
i.e., a specific detection method for biometals and biometalloids, and a separation method based on the 
physical and chemical properties of biomolecules containing metals and metalloids. High-performance 
liquid chromatography (HPLC) is the most popular among the many techniques used for speciation such as 
gas chromatography, gel electrophoresis and capillary electrophoresis5. Indeed, HPLC has several 
advantages over other separation techniques: 1) the separation conditions are relatively similar to the 
physiological conditions, and 2) diverse methods such as gel filtration, ion exchange, affinity and reversed 
phase are easily selectable. On the other hand, inductively coupled plasma–mass spectrometry (ICP-MS) 
has enabled multi-elemental detection with extremely high sensitivity and the discrimination of isotopes. 
Therefore, the coupling of HPLC with ICP-MS has been most widely used for speciation. 
 The speciation analyses of such biological samples as blood plasma, tissue extract and urine 
using conventional HPLC require relatively large volumes of sample at the µL level. However, the volumes 
of samples including extracts of gene-modified cells, digested spots from two-dimensional (2D) 
electrophoresis and tissue biopsy extracts are limited in recent metallome research. Thus, an analytical 
technique for samples having ultrasmall volumes, i.e., a micro/capillary HPLC-ICP-MS, is needed in place 
of conventional HPLC6,7. Although most of the commercially available micro/capillary columns are 
reversed phase ones, the gel filtration column has gained increasing popularity because it possesses many 
advantages for the separation of biomolecules, as follows: 1) it can be used for biological fluids that have 
not been subjected to any pretreatment, such as tissue supernatant, 2) the elution conditions are similar to 
physiological conditions, i.e., elution is normally performed with a salt-containing solution, and 3) the gel 
filtration column can be used for biomacromolecules of various sizes, such as proteins and nucleic acids. 
Indeed, the applicability of a micro gel filtration HPLC-ICP-MS system was shown in the speciation of 
selenocompounds in biological fluids8. On the other hand, micro-sized ion-exchange columns are also 
required for the separation of biomolecules. In particular, 2D micro HPLC (gel filtration plus ion exchange) 
may provide novel information for the speciation of metallomes. However, optimization of the interface 
between the micro/capillary HPLC and ICP-MS is needed. 
 It was recently reported that the introduction of small interfering RNA (siRNA) induces specific 
and potent gene silencing effects in many species9,10. This phenomenon, called RNA interference (RNAi), 
is employed in one of the most powerful and useful molecular biological techniques to show protein 
function, called gene knockdown. Gene knockdown is sometimes used in place of gene knockout in 
experimental animals. Knockout mutation in a critical gene causes embryonic lethality. However, 
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knockdown can control the expression of such a critical gene in cultured cells; thus, this technique can 
provide novel information on protein function.  
 Metallothionein (MT) is a cysteine-rich low molecular weight protein. Mammals have at least 
four MT isoforms locating on an identical chromosome. Two of them are ubiquitously expressed in all 
tissues and cell types, and are called classical MTs, i.e., MT-I and MT-II11,12. The primary structures of 
these two MTs are highly homologous with each other compared with those of the other two isoforms, 
MT-III and MT-IV. Although an immunological assay using antibody raised against each classical MT 
isoform has been reported13, analytical techniques using the antibodies are not common because of 
difficulty of preparation. Therefore, anion-exchange HPLC, which separates MT-I and MT-II based on their 
isoelectric points, is the method of choice14,15. The biological roles of these MT isoforms are proposed as 
follows: detoxification of metals including non-essential and excess essential metals, storage of essential 
metals16, sequestration of reactive oxygen and nitrogen species (ROS and RNS, respectively) and 
electrophiles17-19, and intracellular trafficking of zinc (Zn)20. Although it is known that these MT isoforms 
behave differently in chemical reactions such as oxidative degradation21, it is not known whether there are 
any differences in the biological roles mentioned above between the two isoforms. Two strains of MT 
knockout mouse are available, but both MT-I and MT-II are simultaneously knocked out in those 
strains22,23. Thus, they are inappropriate for use in the investigation of the differences in the biological 
function of classical MTs. 
 In this study, we constructed a 2D micro HPLC-ICP-MS system that consists of a gel filtration 
column and an anion-exchange column to separate two MT isoforms. To enhance the sensitivity of ICP-MS 
for the detection of the metal bound to MT, a low-volume spray chamber with sheath flow was newly 
designed and an enriched stable isotope was used. Further, MT-I and MT-II genes were specifically 
knocked down with the siRNA technique, and the effects of the siRNAs were evaluated using the 2D micro 
HPLC-ICP-MS system. 
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Materials and methods 
 
Materials and reagents 
Cadmium acetate (96.3 % enriched in 113Cd) was purchased from Oak Ridge National Laboratory 
(Oak Ridge, TN, USA). Tris(hydroxymethyl)aminomethane (Trizma®-Base) was purchased from Sigma (St. 
Louis, MO, USA). 1,3-Propanediamine HCl of analytical grade, standard solution of 1,000 mg/L rhodium 
(Rh) dissolved as Rh(NO3)3, and other reagents of the highest grade were purchased from Wako Pure 
Chemical Industries Co., Ltd. (Osaka, Japan). 
 
Cell culture 
Mouse Hepa 1-6 cells were obtained from the RIKEN BioResource Center (Tsukuba, Japan). 
Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma) supplemented with 10 % 
heat-inactivated fetal bovine serum (FBS; Thermo Trace Ltd., Melbourne, Australia), 100 U/mL of 
penicillin (Invitrogen, Tokyo, Japan) and 100 µg mL-1 (Invitrogen) at 37° C under 5 % CO2 atmosphere. 
 
Gene knockdown with siRNAs 
Double-stranded RNAs (dsRNAs) specifically targeting MT-I and MT-II were designed 
according to the manufacturer’s instructions (BLOCK-iT™ RNAi Designer, Invitrogen, found online at 
https://rnaidesigner.invitrogen.com/rnaiexpress/), and were chemically synthesized and used as siRNAs 
(Stealth RNAi, Invitrogen). The targeted sequences of MT-I and MT-II were as follows: siRNA_MT-I, 
CTGCAAGAACTGCAAGTGCACC and siRNA_MT-II, TGCAAAGAGGCTTCCGACAAGTGCA, 
respectively. Hepa 1-6 cells were seeded on a six-well plastic plate at 3.0 x 105 cells/well, and were 
pre-incubated for 24 h. The pre-incubated cells were either transfected or not transfected with 100 nM 
siRNA targeting MT-I or MT-II in the medium optimized for siRNA transfection (Opti-MEM®I, Invitrogen) 
containing 1.0 % Lipofectamine™2000 (Invitrogen), and exposed to 1.0 µM 113Cd-enriched Cd(CH3COO)2 
1 h after the transfection. The cells were harvested 23 h after the Cd exposure and subjected to RT-PCR and 
2D micro HPLC-ICP-MS, as mentioned below. 
 
Isolation of RNA and mRNA determination by reverse transcription polymerase chain reaction 
Because of the high homology between MT-I and MT-II mRNAs, cDNA probes specifically 
hybridizing with MT-I or MT-II mRNA are not available. Thus, reverse transcription polymerase chain 
reaction (RT-PCR) is the only method that can discriminate MT-I mRNA from MT-II mRNA. Hepa 1-6 
cells were seeded on a 6-cm plastic dish at 3.0 x 105 cells/well, and treated with isoform-specific siRNA 
and 113Cd-enriched Cd(CH3COO)2 using the same protocol as that mentioned above. Total RNA was 
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isolated from the cells with Isogen® (Wako Pure Chemical Industries Co., Ltd.), following the protocol 
provided by the manufacturer. RT-PCR was performed in one tube with a Titanium® One-Step RT-PCR kit 
(BD Biosciences, Palo Alto, CA, USA). Gene-specific primers used for amplification of mouse MT-I 
(GenbankTM Data Bank accession number, BC027262), MT-II (BC031758) and E-actin cDNA were as 
follows: MT-I-F, 5’-ATGGACCCCAACTGCTCCTGCTCCACC-3’; MT-I-R, 
5’-GGGTGGAACTGTATAGGAAGACGCTGG-3’; MT-II-F, 5’-CAAACCGATCTCTCGTCGAT-3’; 
MT-II-R, 5’-GAGAACGGGTCAGGGTTGTA-3’; E-actin-F, 5’-GTGGGCCGCTCTAGGCACCAA-3’; 
E-actin-R, 5’-CTCTTTGATGTCACGCACGATTTC-3’. RT-PCR was conducted under the following 
conditions: reverse transcription of cDNA at 50°C for 60 min, denaturation of the reverse transcriptase at 
94°C for 5 min, and 24 (for E-actin) or 27 (for MT-I and MT-II) cycles of PCR, i.e., denaturation of cDNA 
at 94°C for 30 s, annealing at 55°C for 30 s and extension at 68°C for 1 min. A 10-µl portion of the PCR 
products was loaded on a 5% non-denaturing polyacrylamide gel and electrophoresis was conducted at 100 
V for 40 min. The PCR product sizes of MT-I, MT-II and E-actin were 259, 312 and 540 bp, respectively. 
After the run, the gel was soaked for 30 min in 10,000-fold diluted SYBR SafeTM (Molecular Probes, 
Eugene, OR, USA), a fluorescent reagent that stains DNA. The DNA bands were viewed and quantified 
with an image analyzer (LAS2000; Fuji, Tokyo, Japan). 
 
Sample Preparation for 2D micro HPLC-ICP-MS 
Hepa 1-6 cells were seeded on a 6-cm plastic dish at 3.0 x 105 cells/well, and treated with 
isoform-specific siRNA and 113Cd-enriched Cd(CH3COO)2 using the same protocol as that mentioned 
above. The cells were collected with a cell scraper, washed three times with phosphate-buffered saline, and 
diluted to 2.0 x 104 cells/µL with 10 mM Tris-HCl, pH 7.2. The suspended cells were disrupted with an 
ultrasonic homogenizer (Bioruptor® UCD-200, Cosmo Bio Co., Ltd., Tokyo) on ice with a 200 W, 20 kHz 
ultrasonicator for 30 s three times at 30-s intervals. The cytosolic fraction for 2D micro HPLC-ICP-MS 
analysis was obtained by ultracentrifugation of the homogenate at 105,000 g for 60 min at 4°C. 
 
2D micro HPLC 
The 2D micro HPLC system (Prominence, Shimadzu, Kyoto, Japan) used in this work is 
illustrated in Figure 1a. A micro gel filtration column packed in a polyether·ether·ketone (PEEK) housing 
(Shodex Protein KW802.5-M8E; exclusion size, >60 kDa; 0.8 mm i.d. x 250 mm) and a micro 
anion-exchange column packed in a PEEK housing (Shodex DEAE9-M8B; 0.8 mm i.d. x 50 mm) were 
kindly provided by Showa Denko (Tokyo). A 100-nL aliquot of cell cytosol was applied to the 
first-dimension (1D) gel filtration column. The eluate containing MT isoforms from the 1D column was 
pooled in a 10-µL loop via a six-port switching valve, and introduced into the second-dimension (2D) 
anion-exchange column. The chromatographic conditions are given in Table 1. The eluate from the 2D 
column was injected into an ICP-MS (Agilent7500cs; Yokogawa Analytical Systems, Hachiouji, Japan) 
through the interface consisting of a total consumption nebulizer kindly provided by Professor Andreas 
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Prange (GKSS-Research Centre, Geesthacht, Germany) and a low-volume (4.5 mL) spray chamber with an 
in-house designed sheath flow (Figure 1b). The operating conditions of the interface are summarized in 
Table 2. 
 
ICP-MS 
The operating conditions of ICP-MS are shown in Table 2, and other parameters such as lens 
voltage and quadrupole bias were optimized daily to obtain the highest intensities of 7Li, 89Y and 205Tl. 
Optimization of the interface between the 2D micro HPLC and the ICP-MS was done using 100 µg/L of an 
103Rh standard solution. The metals in the eluate were monitored at m/z 65 (Cu), 66 (Zn), 111(Cd) and 113 
(Cd). 
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Results and discussion 
 
 
Hyphenation of 2D micro HPLC with ICP-MS 
At the initial stages of hyphenation between the 1D micro HPLC and the ICP-MS, a conventional 
spray chamber designed for hyphenation of capillary electrophoresis to ICP-MS was used24. It has a 
sheathless, single path and a 90°-bent shape. However, as the bent shape was ineffective for the connection 
of a micro/capillary HPLC to an ICP-MS, a spray chamber was newly designed to improve signal 
sensitivity and stability of ICP-MS detection, as depicted in Figure 1b. Indeed, the sensitivity and stability 
were improved by using the sheath flow spray chamber. Whereas the maximum sensitivity of 100 µg L-1 
Rh used as tuning solution was 2.26 x 105 cps when the conventional chamber was employed under our 
operating conditions, the maximum sensitivity was increased to 3.66 x 105 cps when the sheath flow spray 
chamber was used. The signal stability, which was expressed as the relative standard deviation (RSD) for 
200 data points, was also improved from 2.77 % to 1.59 % by using the sheath flow spray chamber. 
Recently, it was reported that MT isoforms were one-dimensionally separated on a capillary 
reversed-phase (C8) column25. In that study, the MT isoforms applied to the column were purified proteins. 
Thus, as shown in this study, 2D separation may be required to separate MT isoforms in the presence of 
matrices such as cell supernatant.  
As the gel filtration column used for 1D separation, a column containing silica gel based resin 
was chosen based on a previous study that used the resin in a column of conventional size for the MT 
isoform separation26. In this study, two columns having different exclusion sizes were evaluated for the 1D 
separation. The column having a larger exclusion size (KW803-M8E) gave poorer separation of MT, 
carbonic anhydrase III binding zinc, and SOD1 binding copper and zinc, than the column with a smaller 
exclusion size (KW802.5-M8E) (Figure 2). 
 
Separation of MT isoforms on 2D micro HPLC-ICP-MS 
In this study, 113Cd-enriched Cd was used to enhance the detection of MT as a Cd peak by 
ICP-MS. Cd in biological samples is generally detected at m/z 111 or 113 to avoid isobaric interference. 
The isotope abundances of 111Cd and 113Cd are 12.8 and 12.2 %, respectively. Since Cd enriched in 96.3 % 
113Cd was used in this study, the detection level of enriched Cd at m/z 113 was increased by 7.9 times 
compared with that of the non-enriched one27. Indeed, both MT-I and MT-II, which bind to 113Cd, were 
clearly detected with the 2D micro HPLC-ICP-MS system (Figure 3). 
MT-I and MT-II were eluted at the retention times of 26.0 and 28.8 min, respectively, on the 2D 
anion-exchange column (Figure 3). In our previous study, Tris buffer was used as an eluent to separate MT 
isoforms on an anion-exchange column26. However, volatile salts may be more suitable than non-volatile 
salts such as Tris to prevent salt deposition on the spray chamber and salt clogging in the capillary tubing. 
Thus, 1,3-propanediamine HCl, a volatile salt, was used in place of Tris. This salt gave good separation 
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under alkaline conditions because the MT isoforms were retained well on the micro anion-exchange 
column at the initial concentration. Although the MT isoforms are normally acetylated at their N-termini, it 
has been reported that non-acetylated MT isoforms appear under specific physiological conditions such as 
an early stage of MT induction. On an anion-exchange column of conventional size, non-acetylated MT 
isoforms were eluted slightly faster than the corresponding ND-acetylated isoforms26,28. On the micro 
column, despite the fact that both MT isoforms were eventually separated, it might be difficult to separate 
the post-translationally modified MT isoforms under the conditions currently used. 
 
RT-PCR evaluation of MT-Isoform-specific knockdown 
The fluorescence intensities of the RT-PCR products of MT-I and MT-II mRNAs were increased 
by 3.57 ± 0.30 and 18.1 ± 2.94 times, respectively, by the Cd treatment (Figure 4). Treatment with MT-I 
siRNA inhibited the induction of MT-I (1.03 ± 0.46 compared with control). On the other hand, the 
expression of MT-II was not affected by the MT-I siRNA treatment, suggesting that MT-I siRNA 
specifically inhibited the induction of MT-I. The treatment with MT-II siRNA gave similar results to that of 
MT-I siRNA treatment, i.e., the Cd-induced MT-II expression was decreased from 18.1 ± 2.95 to 2.22 ± 
1.27 times of the control, whereas that of MT-I was not apparently reduced. Although MT-I and MT-II have 
high identity (75 %) and homology (82 %) of their amino acid sequences,12 siRNAs specifically designed 
for MT-I and MT-II were able to decrease the expression of their targets at the mRNA level. 
 
2D micro HPLC-ICP-MS evaluation of MT-Isoform-specific knockdown 
As shown in Figure 2, the expression of MT-I and MT-II proteins, which was expressed as 113Cd 
peak intensity, was 3,800 and 4,650 cps, respectively, on treatment with Cd. The expression of MT-I was 
decreased to 2,200 cps whereas that of MT-II was not (4,900 cps) on treatment with MT-I siRNA (Figure 
5a). On the other hand, the expression of MT-I and MT-II was 3,430 and 860 cps, respectively, on treatment 
with MT-II siRNA (Figure 5b). One of the advantages of 2D micro HPLC-ICP-MS over RT-PCR is that the 
protein expression of both isoforms can be directly compared in terms of 113Cd peak intensity. MT-II siRNA 
was found to more effectively and specifically knock down its target gene than MT-I siRNA. Although 
MT-I mRNA expression was completely inhibited by MT-I siRNA treatment (Figure 4), MT-I protein 
actually existed, albeit in a small amount (Figure 5a). These results suggest that the results of RT-PCR do 
not always reflect MT protein expression. Therefore, 2D micro HPLC-ICP-MS may have an advantage 
over RT-PCR in evaluating the effects of siRNA and in estimating the protein expression of MT isoforms in 
gene-modified cells. 
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Table 1. Experimental chromatographic conditions. 
 
  First dimension Second dimension 
 Column Shodex KW802.5-M8E Shodex DEAE9-M8B 
 Size 0.8 mm i.d. x 250 mm 0.8 mm i.d. x 50 mm 
 Separation mode gel filtration anion exchange 
 Eluent 25 mM Tris-HCl, pH 7.2 A: 2 mM 1,3-propanediamine HCl, pH 9.0 
   B: 100 mM 1,3-propanediamine HCl, pH 9.0 
 Eluent flow rate/µL min-1 4.0 4.0 
 Elution program isocratic gradient 
   0-10 min 100 % A 
   10-15 min 0-40 % B 
   15-30 min 40-100 % B 
   30-40 min 100 % B 
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Table 2. Operating conditions of the interface and ICP-MS. 
 
Interface setting 
Nebulizer type total consumption 
Sample carrier gas (Ar) flow/L min-1 1.05 
Sheath gas (Ar) flow/L min-1 0.25 
ICP-MS setting 
RF power/W 1,500 
Auxiliary gas flow/L min-1 1.15 
Plasma gas flow/L min-1 15.0 
Data acquisition 
m/z monitored 65, 66, 111, 113 
Dwell time/ms 100  
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Figure 1. (a) Schematic diagram of the 2D micro HPLC-ICP-MS system. A, B and C: low-flow (micro) 
pumps, D: injector, E: mixer, F: system controller, G: valve switching unit, H: six-port switching valve, I: 
1D micro column (gel filtration), J: 2D micro column (anion exchange), K: photodiode array 
spectrophotometer, L: total consumption nebulizer, M: low-volume sheath flow spray chamber, N: plasma 
torch. (b) Detailed view of the spray chamber. 
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Figure 2. Elution profiles of Zn and Cd in liver supernatant of rat treated with non-enriched Cd. One male 
Wistar rat, 6 weeks of age, was intraperitoneally injected with non-enriched cadmium chloride at a dose of 
2.0 mg Cd kg-1 body weight. The liver was removed and the supernatant was prepared by 
ultracentrifugation of the liver homogenate at 105,000 g for 60 min at 4° C. The supernatant was applied to 
two gel filtration columns that have identical size but different exclusion sizes, i.e., Shodex Protein 
KW803-M8E (Showa Denko; exclusion size, >170 kDa; 0.8 mm i.d. x 250 mm; panels a and b) and 
Shodex Protein KW802.5-M8E (Showa Denko; exclusion size, >60 kDa; 0.8 mm i.d. x 250 mm; panels c 
and d). The columns were evaluated for the separation of MT, SOD1 and CAIII to select the most suitable 
column for use as the first dimension. 
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Figure 3. Elution profiles of 113Cd from the cytosolic fraction of 113Cd-enriched Cd(CH3COO)2 treated 
Hepa 1-6 cells on the 1D gel filtration column (a) and the 2D anion-exchange column (b). The 113Cd 
distributions on the 1D and 2D columns were monitored by ICP-MS. The gradient program is depicted by a 
broken line. 
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Figure 4. Effect of RNAi-mediated isoform-specific silencing on the mRNA expression of MT-I and MT-II. 
Hepa 1-6 cells were either transfected or not transfected with the isoform-specific siRNA of MT-I (a) or 
MT-II (b), and then exposed to 113Cd-enriched Cd(CH3COO)2 1 h after the siRNA transfection. Total RNAs 
were extracted, and MT-I and MT-II mRNAs were determined by RT-PCR. Cells treated with neither 
siRNA nor Cd served as control. The data are expressed as means ± standard deviation of three independent 
experiments. The significant difference was calculated by the Student’s t-test. The level of significance was 
set at p <0.05. 
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Figure 5. Effect of RNAi-mediated isoform-specific silencing on the protein expression of MT-I and MT-II. 
Hepa 1-6 cells were either transfected or not transfected with the isoform-specific siRNA of MT-I (a) or 
MT-II (b), and then exposed to 113Cd-enriched Cd(CH3COO)2 1 h after the siRNA transfection. The 
cytosolic fraction of the cells was injected into the 2D micro HPLC-ICP-MS system. 
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Chapter 2 
 
 
Speciation of copper and determination of 
metallothionein mRNA in mutant mouse neonates 
bearing a defection in Cu metabolism 
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Abstract 
 
 The minute amounts of tissue supernatants from mouse neonates bearing a mutation in a 
copper (Cu)-transporter gene, Atp7a, were applied on the narrow bore HPLC coupled with an 
inductively coupled plasma mass spectrometer (ICP-MS) to reveal the Cu metabolism. In the mutant 
neonates at 14 days after the birth, Cu accumulated in the intestine in the form bound to 
metallothionein (MT) and mRNA expressions of two MT isoforms also increased, while Cu bound 
to MT in the liver was depleted in comparison with wild type mice and mRNA expressions also 
decreased. These suggest that Cu is not secreted from microvillus cells on the intestine to 
bloodstream due to the defection of Atp7a, and systemic depletion of Cu occurs. On the other hand, 
Cu was also accumulated in the form bound to MT despite mRNA of two MT isoforms were not 
induced in the kidneys of mutant mice. This suggests that MT binding Cu (Cu-MT) in the kidneys is 
not bio-synthesized in situ but it may be originating from the intestine owing to leakage of Cu-MT 
from microvillus cells to bloodstream. Consequently, mRNA expressions of MT isoforms were not 
always coincident with the amounts of MT proteins binding Cu, thus, the narrow bore 
HPLC-ICP-MS was more precisely indicate the MT expression in the Cu metabolism than the 
mRNA determination. 
 
 
  - 25 - 
Introduction 
 
 
Copper (Cu) is an essential trace element in all living organisms. It functions as the active 
center of cuproenzymes such as cytochrome c oxidase (CCO), which is a component of the 
mitochondrial respiratory chain, and Cu,Zn-superoxide dismutase (Cu,Zn-SOD, SOD1), which 
protects cells from superoxide anion, a kind of ROS. Recently, molecular mechanisms underlying 
the Cu metabolism have been depicted by the large contributions of molecular biology as mentioned 
below. Cuprous ions (Cu (I)) are incorporated into cells by Ctr1, a transporter expressed on the 
cytoplasmic membrane, and then the incorporated Cu is associated with one of three Cu chaperones, 
i.e., antioxidant protein 1 (Atox1), Cu chaperone for superoxide disumutase (Ccs) and cytochrome c 
oxidase, subunit 17 (Cox17), a group of proteins required for binding to imported Cu and delivering 
it to specific target proteins within the cell. Atox1 delivers Cu to ATP-dependent transports carrying 
the Cu efflux, i.e., ATPases named Atp7a and Atp7b on Golgi apparatus1. Atp7b specifically 
expresses in the liver and mammary gland while Atp7a expresses in other organs. These ATPases 
have a dual function, to transport Cu from the cytosol to Golgi apparatus via Atox1 in order to 
incorporate Cu into secreted cuproenzymes, and to excrete excess Cu from cells by relocalize onto 
plasma membrane. The dysfunction of ATP7A causes Cu deficiency known as human Menkes 
disease and the occipital horn syndrome (OHS). The Cu deficiency is resulting from defection of Cu 
transport from microvillus cells on the intestine to bloodstream. 
Metallothionein (MT) is also suggested as a Cu-regulating protein, especially, it is induced 
by excess Cu to mask the Cu toxicity. In addition to the protective role against excess Cu, alleviative 
role of MT against Cu deficiency was also suggested2. 
The mouse bearing a dysfunction of Atp7a (murine homologue to ATP7A) is an animal 
model of OHS because of the similar mutation in its gene to OHS patients, and is named blotchy 
mouse3,4. The hemizygote bearing the mutation in Atp7a located on the X-chromosome, i.e., the 
male blotchy mouse, shows typical symptoms of Cu deficiency such as connective tissue disorder, 
neurological impairment, and hypopigmentation, and these symptoms are a result of the dysfunction 
of the following cuproenzymes: lysyl oxidase, dopamine E-hydroxylase, and tyrosinase, respectively 
4. In addition to these symptoms, the mouse shows severe growth retardation and dies before 
weaning. Thus, the organs from this neonatal mouse are too small for use with conventional 
HPLC-ICP-MS.  
Miniaturization of the liquid separation technique in the hyphenated technique is one of 
the recent trends in analytical chemistry5. Indeed, the development of capillary and nano HPLC 
coupled with an inductively coupled plasma ,ass spectrometer (ICP-MS) has been reported6-9 and 
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their advantages have been shown, including high separation efficiency, low solvent consumption, 
the possibility of introducing organic solvents at high concentrations into ICP-MS, and applicability 
to a minute amount of sample10. In the present study, HPLC-ICP-MS equipped with a narrow bore 
gel filtration column was developed to analyze the minute amount of tissue extract, and then the 
relevance between the amount of Cu in the form bound to MT (Cu-MT) and the expression of MT 
mRNA was evaluated to reveal the Cu metabolism in the mutant animal model. 
 
  - 27 - 
Materials and methods 
 
 
Reagents 
Milli-Q water, 18.3 M:/cm, (Millipore) was used throughout. 
Tris(hydroxymethyl)aminomethan (Trizma®Base) was purchased from Sigma (St. Lauris, MO, 
USA). Ammonium acetate, acetic acid, 28 % ammonia solution, hydrochloric acid, and other 
reagents of the highest grade were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, 
Japan). 
 
Animal experiments 
All animal experiments were carried out according to the “Principles of Laboratory 
Animal Care” (NIH version, revised 1996) and the Guidelines of the Animal Investigation 
Committee, Graduate School of Pharmaceutical Sciences, Chiba University, Japan. Mice housed in a 
humidity controlled room maintained at 22-25 °C with a 12 h light-dark cycle. Mice were given free 
access to a commercial diet (MF; Oriental yeast, Tokyo, Japan) and tap water ad libitum. 
Heterozygous blotchy mice (C57BL/6 strain) were provided from Hamamatsu University 
School of Medicine (Hamamatsu, Japan). Male wild type mice (C57BL/6 strain) were purchased 
from Clea Japan (Tokyo, Japan) and mated with the heterozygous female. Neonatal hemizygous 
blotchy males and their wild-type littermates were euthanized at 14 days after the birth. The intestine, 
liver, heart and kidneys were excised, and then washed three times with phosphate-buffer saline 
(PBS).  
 
Sample preparation for narrow bore HPLC-ICP-MS 
The organs were homogenized with 50 mM Tris-HCl, pH 7.4 using Teflon homogenizer 
on ice. The cytosolic fraction was obtained by ultracentrifugation of the homogenate at 105,000 g for 
60 min at 4°C in a 250-µL ultracentrifuge tube (Hitachi Koki Co., Tokyo, Japan). The HPLC system 
(Prominence, Shimadzu, Kyoto, Japan) was used in this work. A narrow bore multi mode 
gel-filtration column (Shodex Protein KW802.5-2E, 2.0 mm i.d. × 250 mm) was kindly provided by 
Showa Denko (Tokyo). A 5.0 µL aliquot of tissues cytosol was applied on the column, and the 
column was eluted with 100 mM ammonium acetate, pH 7.2 at a flow rate of 40 µL/min. The eluate 
was introduced into a micro concentric nebulizer (Burgener Ari Mist HP Nebulizer, Ontario, Canada) 
connected to a cyclone chamber of an ICP-MS (Agilent7500ce; Agilent Technologies, Hachiouji, 
Japan). The column properties and chromatographic conditions were shown in Table 1. The Cu and 
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Zn in the eluate were monitored at m/z 65 and 66, respectively. 
 
Isolation of total RNA and mRNA determination of MT-I and MT-II by real time reverse 
transcription polymerase chain reaction 
Total RNA was isolated from the tissues with Isogens (Wako Pure Chemical Industries, 
Ltd.) according to the protocol provided by the manufacturer. Reverse transcription reaction, the first 
step of real time PCR, was performed with a QuantiTect® Reverse transcription kit (QIAGEN, 
Tokyo, Japan). PCR was performed with ABsoluteTM QPCR SYBR® Green ROX Mix (ABgene, Inc., 
New York, USA). Gene-specific primers used for amplification of mouse MT-I (Genbank™ Data 
Bank Accession No. NM_013602), MT-II (NM_008630) and E-actin cDNA were as follows: 
MT-I-forward (F), 5’-CACCAGATCTCGGAATGGAC-3’; MT-I-reverse (R), 
5’-AGGAGCAGCAGCTCTTCTTG-3’; MT-II-F, 5’-CGCTCCTAGAACTCTTCAAACC-3’; 
MT-II-R, 5’-GAGCAGCAGCTTTTCTTGC-3’; E-actin-F, 5’-TCGCCATGGATGACGATA-3’; 
E-actin-R, 5’-GAGTCCTTCTGACCCATTCC-3’; RT-PCR was conducted under the following 
conditions: reverse transcription reaction of cDNA at 42°C for 15 min, denaturation of the reverse 
transcriptase at 95°C for 3 min, and 40 cycles of PCR. The PCR product sizes of MT-I, MT-II and 
E-actin were 120, 165 and 160 bp, respectively. Fluorescence intensity of the amplified genes was 
determined by ABI PRISM® 7000 SDS (Applied Biosystems, Foster, USA). 
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Results and discussion 
 
 
Speciation of Cu in the tissue supernatants of the mutant and wild type neonatal mice by narrow bore 
HPLC-ICP-MS 
The two major Cu-peaks that eluted at retention times of 11.6 min and 13.0 min were detected in 
all tissue supernatants tested, i.e., the intestine, liver, heart and kidneys (Fig. 1). The former peak was 
accompanied with Zn at the equal molar amount (data not shown), and heat-stable at 72°C suggesting that 
this peak was corresponding to Cu,Zn-SOD (SOD1). On the other hand, the latter one was not detected in 
the tissue supernatants of MT-null mice, and heat-stable at 95°C suggesting that this peak was 
corresponding to MT isoforms. It was already shown that this column could not separate two MT isoforms 
due to their homologous amino acid sequences resulting in shown the resemble molecular size, metal 
binding properties and isoelectric points11. Although the amount of Cu in the form bound to SOD1 was 
diverse among the tissues, there were no apparent differences in peak height corresponding to SOD1 
between the wild type and the mutant mice in all tissues suggesting that the amount of Cu in the form 
bound to SOD1 was maintained even in Atp7a-dysfunctioning mice at this age, i.e., 14 days after the birth. 
Interestingly, the mutant mice showed apparent hypopigmentation at this age suggesting that the activity of 
tyrosinase, the cuproenzyme, was already reduced by the Cu deficiency. Thus, SOD1 may be more 
important cuproenzyme than tyrosinase to maintain the life. However, the mutant mice were unable to 
survive after the weaning, thus, the supplementation of Cu to SOD1 might be reduced after the period. 
Cu bound to MT in the intestine of mutant mice was 6 times larger than that of wild type mice 
(Fig. 1a). As already mentioned, Cu ingested from the mother milk was accumulated in the intestine of the 
mutants due to the defection of Atp7a in microvillus cells of the intestine, and accumulated Cu was 
sequestered with MT to mask its toxicity in cells. The microvillus cells are rapidly turned over, thus, 
Cu-MT accumulated in the cells seemed to be mainly excreted into feces. 
There are reports that Cu was accumulated in neonatal liver in the form bound to MT, although 
its biological functions and mechanisms are still unclear12,13. Indeed, Cu in the form bound to MT was 
observed in the liver supernatant of wild type (Fig. 1b, black line). Despite the amount of Cu in the form 
bound to SOD1 in mutant mice was comparable to that in wild type, the amount of Cu in the form bound to 
MT in blotchy mutant was severely decreased (Fig. 1b, blue line). Since the absorption of Cu from the gut 
is defected, the systemic Cu deficiency is induced in the mutant mice. The liver was one of the typical 
organs indicating the Cu deficiency.  
In the heart, there were no apparent differences in the Cu elution between the wild type and 
mutant mice (Fig. 1c). The role of MT in the Cu metabolism may be marginal comparing to other organs 
analyzed.  
Although the kidneys might be also deficient in the Cu amount like the liver, the amount of Cu in 
the form bound to MT in the kidney of the mutant mice was 8 times larger than that of the wild type (Fig. 
1d). The explanations for this result was mentioned later combined with the results obtained from the 
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determination of mRNA. The amount of Cu bound to SOD1 in the kidneys of the mutant was entirely the 
same as that of the wild type. 
 
Determination of mRNA in the tissues of the mutant and wild type neonatal mice 
The mRNA amounts of MT-I and MT-II in the intestine of mutant were 3 times larger than those 
of the wild type mice, and were consistent with the amount of Cu bound to MT (Fig. 2a). These suggest 
that MT was induced in situ by Cu accumulated in the intestine, i.e., the transcription of MT mRNA was 
enhanced by Cu, and mRNA was translated to MT protein, and then the MT protein sequestered Cu. The 
expressions of MT mRNA in the liver of mutant showed the tendency to decrease in comparison with those 
of the wild type mice. These results were also coincident with the results of the Cu distributions on the liver 
(Fig. 2b). There no significant changes in the mRNA expressions between the wild type and mutant mice as 
observed in the Cu distributions in this organ (Fig. 2c). 
On the other hand, although Cu was accumulated in the form bound to MT in the kidney 
supernatant of mutant mice, the mRNA expressions of MT-I and MT-II in the mutant showed slightly small 
and comparable to the wild type, respectively (Fig. 2d). These meant that the transcription of MT was not 
induced but Cu bound to MT was increased. The similar phenomenon such as the lack of correlation 
between the renal MT mRNA expression and the renal Cu concentration was reported in brindled mutant 
mice which were of another strain bearing the dysfunction of Atp7a. There are some explanations for these 
phenomena, i.e., the extension of metabolic turn over of MT proteins, the post-translational regulation of 
MT proteins and the existence of apo- and/or Zn-metallothionein in the kidneys. However, there were no 
considerable changes in the chromatographic behavior of MT to indicate any structural features being 
relevant with the protein turn over and the post-translational modifications. There were also no changes in 
the Zn elution in the kidney supernatants of the wild type and mutant mice (data not shown). As another 
explanation, it is known that cadmium (Cd) bound to MT targets to the kidneys despite the Cd ion 
accumulates in the liver14. Cd administered as a Cd salt was initially accumulated and sequestered with MT 
in the liver, and then Cd-MT was released during hepatic damage and taken up by the kidneys14. According 
to this scheme, Cu accumulated in the kidneys is suggested to be taken up as Cu-MT bio-synthesized in the 
other organs, perhaps the intestine. Thus, a part of Cu-MT in the microvillus cells may be released into 
bloodstream at the turn over and preferably taken up by the kidney. This seems to be reasonable to explain 
the accumulation of Cu-MT without the expression of MT mRNA. 
Because of the high homology between MT-I and MT-II, cDNA probes specifically hybridizing 
with MT-I and MT-II are not available. Thus, the method based on the PCR using isoform-specific primers 
is the only technique to discriminate between MT-I and MT-II mRNA. Particularly, real time RT-PCR is of 
higher quantitative than the other methods. However, as shown in this study, the amount of MT mRNA 
determined by even real time RT-PCR was not precisely coincident with the amount of MT bound to Cu in 
the kidney of the mutant mice because MT binding Cu in the kidney may be not induced in situ. 
As mentioned above, the narrow bore HPLC-ICP-MS is applicable to a minute amount of 
samples such as neonatal and fetal tissues. Although SOD1 or MT isoforms are detected by the narrow bore 
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HPLC-ICP-MS, Cu chaperones are unable to detect by current techniques due to their small amounts in 
tissue supernatant. For instance, it was reported that the amount of Ccs was one-twelfth as that of SOD1 
which was the target or partner of Ccs15. At least, ten or more times sensitive higher than the current is 
required to reveal the dynamics of Cu by Cu chaperones. Therefore, the speciation of Cu performed by the 
narrow bore HPLC-ICP-MS acts as a complementary technique of the mRNA determination to reveal the 
Cu metabolism. 
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Table 1. Comparison of chromatographic parameters and interface type between narrow bore 
and conventional HPLC. 
 
 narrow bore HPLC conventional HPLC 
 Chromatographic parameter 
 Column Shodex Protein KW802.5-2E Shodex Protein KW-802.5 
 Size (mm) 2.0 i.d. x 250 8.0 i.d. x 300 
 Theoretical plate number >12,000 >20,000 
 Injection volume (µL) 1.0-5.0 20-200 
 Flow rate (µL min-1) 40 600 
 Interface type 
 Nebulizer micro concentric Babington 
 Spray chamber cyclone Scott 
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Figure 1. Cu elution profiles of the supernatants of neonatal tissues. Cu in the supernatants of the intestine 
(a), liver (b), heart (c) and kidneys (d) was determined by the narrow bore HPLC-ICP-MS. A 5.0 µL aliquot 
of the supernatants from blotchy mutant and wild-type mice on 14 days after birth was applied to a 
KW802.5-2E column, and the column was eluted with 100 mM ammonium acetate, pH 7.2 at a flow rate of 
40 µl/min. 
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Figure 2. Relative mRNA expression of MT-I and MT-II in the tissues of blotchy mutant and wild-type 
mice. The amounts of MT-I and MT-II mRNA in the intestine (a), liver (b), heart (c) and kidneys (d) were 
determined by real time RT-PCR. The relative mRNA expression in blotchy mutant (blue columns) was 
compared with that of wild-type littermates (white columns) on 14 days after birth. Columns and bars 
represent means ± standard deviations (SD) for three mice. 
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Chapter 3 
 
 
Detoxification mechanisms for copper accumulation 
in mouse fibroblast lacking metallothionein and 
copper chaperone, Atox1 
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Abstract 
 
 
Copper (Cu) is the active center of some enzymes because of its redox-active property, although 
that property could have harmful effects. Because of this, cells have strict regulation/detoxification systems 
for this metal. In this study, multi-disciplinary approaches, such as speciation and elemental imaging of Cu, 
were applied to reveal the detoxification mechanisms for Cu in cells bearing a defect in Cu-regulating 
genes. Although Cu concentration in metallothionein (MT)-knockout cells was increased by the knockdown 
of the Cu chaperone, Atox1, the concentrations of the Cu influx pump, Ctr1, and another Cu chaperone, 
Ccs, were paradoxically increased; namely, the cells responded to the Cu deficiency despite the fact that 
cellular Cu concentration was actually increased. Cu imaging showed that the elevated Cu was 
compartmentalized in cytoplasmic vesicles Together, the results point to the novel roles of MT and 
cytoplasmic vesicles in the detoxification of Cu in mammalian cells. 
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Introduction 
 
 
Copper (Cu) is an essential trace element in living organisms. It functions as the active center of 
cuproenzymes, such as cytochrome c oxidase (CCO), Cu,Zn-superoxide dismutase (Cu,Zn-SOD, SOD1), 
ceruloplasmin, lysyl oxidase, tyrosinase, and dopamine β-hydroxylase1. The mechanisms underlying Cu 
homeostasis are suggested as follows2. Cu is mainly incorporated into cells as a monovalent Cu ion, i.e., 
cuprous ion, by Ctr1, a transporter expressed on the plasma membrane3,4. Incorporated Cu associates with 
one of three cytoplasmic Cu escort proteins, the so-called Cu chaperones, for it to be escorted to specific 
organelles or cuproenzymes. Atox1, a Cu chaperone for the Golgi apparatus, hands over Cu to Atp7a and 
Atp7b, which are ATP-dependent Cu transporters into the secretory pathway of Cu via the Golgi 
apparatus5,6. In the Golgi apparatus, Cu is incorporated into cuproenzymes, such as ceruloplasmin and lysyl 
oxidase, due to the secretion of these cuproenzymes into extracellular fluid. Otherwise, Cu is directly 
excreted from cells by secretory vesicles that translocate to the plasma membrane to exocytose Cu. Cox17, 
a Cu chaperone for the mitochondria, is required to donate Cu to CCO and/or SCO1, which is a recipient 
protein of Cu on the mitochondrial membrane7,8. CCS, a Cu chaperone for SOD1, transports Cu to SOD1 in 
cytosol by forming a heterodimer with SOD1. In addition to these Cu chaperones, a novel Cu-regulating 
protein, Commd1, was recently characterized9. It does not have apparent Cu-binding motifs in its molecule 
but is proposed to participate in the Cu efflux pathway by interacting with Atp7b10. Indeed, Bedlington 
terriers demonstrated inherited hepatic Cu toxicosis due to a defect in Commd111. Metallothionein (MT) is 
suggested to be also a Cu-regulating protein. It actually binds Cu via Cu-thiolate clusters12. Since MT 
binding of Cu is thermodynamically and kinetically stable, excess Cu is sequestered by MT to mask Cu 
toxicity13. On the other hand, an alleviative role of MT in Cu deficiency was also suggested14,15. Thus, MT 
may play a dual role in Cu homeostasis in mammalian cells. 
 As mentioned above, Cu is regulated by various proteins, such as transporters across the 
membrane, chaperones in the cytoplasm, and MT that buffers Cu availability in cells. However, this rigid 
regulation may prevent us from experimentally disturbing intracellular Cu concentration and further 
analyzing the mechanisms of Cu regulation. In particular, MT is induced by either an excess or a deficiency 
of Cu to maintain Cu homeostasis. In some cases, it was suggested that MT did not contribute to the 
detoxification of Cu. For instance, it is reported that Formosan squirrels abnormally and inheritably 
accumulated Cu in the liver16. Although other inherited Cu toxicosis animals, such as toxic milk mice and 
Long-Evans Cinnamon (LEC) rats, accumulated Cu in the form bound to MT in their livers17, it was shown 
that Cu accumulated in the liver of Formosan squirrels dominantly existed in the insoluble fraction of the 
liver and only a small amount was bound to MT16. Alternatively, Cu that was rapidly administered to rats 
also existed in the form that was not bound to MT18. However, these animals did not manifest Cu toxicity 
and thus, a detoxification mechanism that functions independently of MT is speculated. In this study, we 
intended to establish an experimental model in which Cu concentration was modified by gene knockdown 
(KD) in a Cu-regulating protein, and to show that the contribution of MT to Cu homeostasis could be 
ignored. In this regard, fibroblasts established from an MT-null mutant mouse, i.e., MT-knockout cells 
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(MT-KO) cells, are frail against the Cu toxicity, and those cells are more useful to reveal Cu homeostasis 
than MT-wild type (MT-WT) cells. Atox1 KD was introduced into MT-KO cells. 
 In the present study, multi-disciplinary approaches were used to reveal the detoxification 
mechanisms for Cu in cells. First, speciation was used to determine the chemical species of Cu in the 
soluble fraction of cells. As the sample from cultured cells was too small to allow for analysis of Cu species 
by conventional HPLC coupled with an inductively coupled plasma mass spectrometer (ICP-MS), micro 
HPLC coupled with ICP-MS was adopted. Second, an elemental fluorescent probe for Cu, Cu sensor 1 
(CS1), was used for Cu imaging. This probe enables visualization of intracellular Cu distribution in live 
cells. Thus, elemental imaging is a complementary technique to elemental speciation in metallochemical 
biology. The aim of this study is to reveal the MT-independent detoxification mechanisms for Cu using 
MT-KO cells bearing Atox1 KD with multi-disciplinary approaches. 
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Materials and methods 
 
 
Reagents 
Milli-Q water (18.3 MΩ/cm, Millipore) was used throughout. All reagents used in this study were 
of the highest grade. 
 
Cell culture and gene knockdown with siRNAs 
MT-wild type (MT-WT) and MT-knockout (MT-KO) cells were established from embryonic 
fibroblasts of 129Sv MT-WT and MT-KO mice transformed with SV40 large T antigen by Kondo et al.45 
and kindly provided by Professor Seiichiro Himeno (Tokushima Bunri University, Japan). Cells were 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) of the high glucose type (4500 mg/l), and 
supplemented with 10% heat inactivated fetal bovine serum, 10 U/ml penicillin, and 100 µg/ml 
streptomycin at 37 °C under 5% CO2 atmosphere. Double-stranded RNAs (dsRNAs) were used as siRNAs 
(Stealth RNAi, Invitrogen, Tokyo, Japan). The targeted sequence of Atox1 was as follows: siRNA_Atox1, 
5′-ACAAGCUGGGAGGAGUGGAGUUCAA-3′. MT-WT and MT-KO cells were seeded on a six-well 
plastic plate at 1.0 x 105 cells/well, and were pre-incubated for 24 h. The pre-incubated cells were either 
transfected or not transfected with 100 nM siRNA targeting Atox1 in the medium optimized for siRNA 
transfection (Opti-MEMsI, Invitrogen), containing 0.6% Lipofectamine 2000 (Invitrogen) for 24 h. The 
cells were harvested 24 h after the transfection and subjected to analysis as mentioned below. 
 
Isolation of total RNA and determination of Cu-regulating gene mRNA expression by real-time reverse 
transcription polymerase chain reaction 
Total RNA was isolated from the cells with an RNAqueous®-Micro Kit (Ambion, Austin, TX, 
USA) according to the protocol provided by the manufacturer. Reverse transcription reaction, the first step 
of real-time PCR (q-PCR), was performed with a QuantiTect Reverse Transcription Kit (Qiagen, Tokyo, 
Japan). PCR was performed with ABsolute QPCR SYBR Green ROX Mix (ABgene, New York, NY, USA). 
Gene-specific primers used in this study were indicated in Supplemental Methods. RT-PCR was conducted 
under the following conditions: reverse transcription reaction of cDNA at 42 °C for 15 min, denaturation 
with reverse transcriptase at 95 °C for 3 min, followed by 40 cycles of PCR, i.e., denaturation of cDNA at 
95 °C for 15 s and annealing and extension at 60 °C for 1 min. PCR product sizes were MT-I (120 bp), 
MT-II (165 bp), Atox1 (148 bp), Ctr1 (160 bp), Ccs (168 bp), Cox17 (143 bp) and β-actin (160 bp). 
Gene-specific primers used for amplification of mouse MT-I (Genbank accession no. NM _013602), MT-II 
(NM_008630), Atox1 (NM_009720), Ctr1 (NM_175090), Ccs (NM_016892), Cox17 (NM_001017429), 
and β-actin cDNAs were as follows: MT-I-forward (F), 5′-CACCAGATCTCGGAATGGAC-3′; 
MT-I-reverse (R), 5′-AGGAGCAGCAGCTCTTCTTG-3′; MT-II-F, 
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5′-CGCTCCTAGAACTCTTCAAACC-3′; MT-II-R, 5′-GAGCAGCAGCTTTTCTTGC-3′; Atox1-F, 
5′-CCGTCTCCAGAGTCCTCAACA-3′; Atox1-R, 5′-GACAAAGGATGGAACCGG-3′; Ctr1-F, 
5′-TGATGATGATGCCTATGACCT-3′; Ctr1-R, 5′-AAGATAGCCCGAGAGGGTC-3′; Ccs-F, 
5′-TATCGATGAGGGGGAAGATG-3′; Ccs-R, 5′-AGTGATAGACCCTCCTCGC-3′; Cox17-F, 
5′-GGAGAAGAAGCCACTGAAGC-3′; Cox17-R, 5′-CTCCCGTGACCCTAAATTC-3′; β-actin-F, 
5′-TCGCCATGGATGACGATA-3′; β-actin-R, 5′-GAGTCCTTCTGACCCATTCC-3′. Fluorescence 
intensity of the amplified genes was determined by ABI PRISM 7000 SDS (Applied Biosystems, Foster, 
CA, USA). 
 
Western blotting 
Cells were lysed in phosphate buffered saline (PBS) containing 1% Triton X-100, 0.1% SDS, 1 
mM EDTA, and a cocktail of protease inhibitors (F. Hoffmann-La Roche Ltd., Basel, Switzerland) for 20 
min on ice. The supernatant for Western blotting was obtained by centrifugation of the lysate for 20 min at 
16,000 g at 4 °C45. The protein samples (50 μg) were electrophoresed through polyacrylamide gels (Ready 
Gel 12% Tris-HCl, 4-20% Tris-HCl, and 10-20% Tris-Tricine/Peptide, Bio-Rad Laboratories, Hercules, CA, 
USA) and transferred to a nitrocellulose membrane at 20 V for 60 min. The membrane was blocked 
overnight with 5% skim milk in 25 mM Tris-HCl containing 0.9% NaCl, 0.05% Tween 20, pH 7.5 (TBS-T) 
at 4 °C, incubated with each antibody, i.e., anti-Ctr1 (1:2000 diluted), anti-Ccs (1:1500), anti-Cox17 
(1:1000), anti-Atox1 (1:500), anti-Atp7a (1:2000), anti-Atp7b (1:2500), anti-SOD1 (1:2500) or anti-β-actin 
(1:5000) in TBS-T for 1 h, and washed three times with TBS-T. A synthetic peptide of the Ctr1 sequence 
H2N-VSIRYNSMPVPGPNGTILC-COOH, which corresponds to the cytosolic loop between 
transmembrane domains 1 and 2 of mouse and human Ctr1, was used as antigen for generation and affinity 
purification of rabbit polyclonal antiserum by Bethyl Laboratories, Inc. (Montgomery, TX, USA). Rabbit 
polyclonal antisera against Atox1, Atp7a, and Atp7b were kindly provided by Professor Jonathan D. Gitlin 
(Washington University School of Medicine, Seattle, WA, USA). Rabbit anti-Cox17 and anti-SOD1 
polyclonal antibodies were purchased from Proteintech Group, Inc. (Chicago, IL, USA) and Assay Designs, 
Inc. (Ann Arbor, MI, USA), respectively. The secondary antibody (1:5000) was incubated with the 
membrane in TBS-T containing 5% skim milk, and washed three times with TBS-T. This rabbit secondary 
antibody was purchased from GE Healthcare Bio-Sciences KK (Tokyo, Japan). The blots were detected 
with Super Signal Pico Chemiluminescent Reagent (Pierce Biotechnology, Inc. Rockford, IL, USA) on an 
X-ray film (HyBlot CLTM 203 x 254 mm, Denville Scientific, Inc. Plainfield, NJ, USA) according to the 
manufacturer’s instructions. 
 
Determination and speciation of metals in cultured cells 
MT-WT and MT-KO cells were seeded and treated with siRNA according to the same protocol as 
that mentioned above. After the treatment, the cells were collected and counted to determine Cu 
concentration. The harvested cells were wet-ashed with nitric acid for 24 h on a hot plate and then diluted 
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with deionized water. Cu concentration in the samples was determined by an inductively coupled plasma 
mass spectrometer (ICP-MS, Agilent7500ce, Agilent Technologies, Hachiouji, Japan) at m/z 65. For the 
determination of Cu concentration in cultured cells, the sample was pneumatically introduced into an 
ICP-MS through an interface consisting of a micro flow nebulizer (PFA-20, Glass Expansion, Pty. Ltd., 
West Melbourne, Australia) and a cyclone chamber (Glass Expansion). 
The cells were collected and suspended to a concentration of 2.0 x 104 cells/µL with 10 mM 
Tris-HCl, pH 7.2, for metal speciation. The suspended cells were disrupted with an ultrasonic homogenizer 
(Bioruptors UCD-200, Cosmo Bio Ltd., Tokyo, Japan) on ice at 200 W, 20 kHz for 30 s three times at 30 s 
intervals. The cytosolic fraction was obtained by ultracentrifugation of the homogenate at 105000 g for 60 
min at 4 °C. The HPLC system (Prominence, Shimadzu, Kyoto, Japan) equipped with a narrow bore 
column was coupled with an ICP-MS (HPLC-ICP-MS) and was used for metal speciation in cultured cells. 
A narrow bore multi-mode gel-filtration column (Shodex Protein KW802.5-2E, 2.0 mm i.d. × 250 mm) was 
kindly provided by Showa Denko (Tokyo, Japan). A 5.0 µL aliquot of cytosol was applied to the column 
and the column was directly eluted with 100 mM ammonium acetate, pH 7.2, at a flow rate of 40 µL/min. 
The eluate was introduced into a micro concentric nebulizer (Ari Mist HP Nebulizer, Burgener Research 
Inc., Ontario, Canada) connected to the cyclone chamber of an ICP-MS. Cu and Zn in the eluate were 
monitored at m/z 65 and 66, respectively. 
 
Elemental fluorescence imaging of Cu 
CS1, a specific imaging probe for monovalent Cu (cuprous) ion, was kindly provided by 
Professor Christopher J. Chang (University of California, Berkeley, California, USA). MT-WT and MT-KO 
cells were seeded and treated with siRNA according to the same protocol as that mentioned above. After 
the treatment, the cells were incubated with 5 µM CS1 dissolved in dimethyl sulfoxide for 120, 180, and 
240 s at 37 °C, and fluorescence of the Cu-CS1 complex in the cells was detected by Axio Observer (Carl 
Zeiss, Oberkochen, Germany) at an excitation wavelength of 543 nm and an emission wavelength of 560 
nm. 
 
Immunofluorescence imaging of Ctr1 
siRNA transfected cells were washed twice with PBS, fixed with 4% formaldehyde in PBS for 30 
min at room temperature, and permeabilized with 0.1% Triton X-100 for 30 min. The cells were washed 
twice with PBS, blocked in 5% skim milk in PBS at room temperature for 24 h, and incubated with the 
primary antibody against Ctr1 (1:100). The complex of Ctr1 and its primary antibody was detected with 
Alexa Fluor® 488 goat anti-rabbit IgG as the secondary antibody (Molecular Probes, Eugene, OR, USA). 
The nuclei were stained with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI, Molecular Probes) 
for 10 min. Coverslips were mounted in ProLong Antifade (Molecular Probes). Alexa Fluor® 488 and 
DAPI fluorescence was detected with a Zeiss Axio Imager wide-field fluorescence microscope (Carl Zeiss) 
at excitation wavelengths of 485 and 387 nm and emission wavelengths of 624 and 447 nm, respectively. 
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Digital fluorescence images were captured using MetaMorph 7.5 system (Molecular Devices, 
Downingtown, PA, USA). 
 
Statistics 
The results are presented as means ± standard deviation (SD) of three independent samples. The 
significant difference was calculated by the Student’s t-test, and a p value of less than 0.05 was considered 
to be statistically significant. 
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Results 
 
 
Effects of Atox1 knockdown on Cu-regulating gene expression  
Relative mRNA expressions of Atox1 in MT-WT and MT-KO cells decreased to 0.25 and 0.23, 
respectively, when cells were treated with Atox1-targeting siRNA (Fig. 1A and 1E). Atox1 protein 
expression in both MT-WT and MT-KO cells was also silenced (Fig. 2A). Relative mRNA expressions of 
Ctr1, Cox17, and Ccs were not significantly changed by the Atox1 siRNA treatment (Fig. 1B, 1C, and 1D), 
and their protein expressions coincided with mRNA expressions (data not shown). In addition, Atp7a, 
Atp7b, and SOD1 protein expressions in MT-WT cells were not also changed by the Atox1 siRNA 
treatment (data not shown). Consequently, although Atox1 protein expression was suppressed by Atox1 KD, 
the expression of other Cu-regulating proteins was not changed in MT-WT cells. On the other hand, Atox1 
KD significantly increased Ctr1 mRNA expression to 2.5 times that of control in MT-KO cells (Fig. 1F), 
and Ctr1 protein expression was increased as well (Fig. 2B). Although Cox17 mRNA expression showed a 
tendency to increase, the increase was not significant (Fig. 1G). Indeed, Cox17 protein expression was not 
changed by Atox1 KD (Fig. 2C). Ccs mRNA expression was not significantly changed (Fig. 1H) but its 
protein expression was apparently increased, suggesting that Ccs protein expression was 
post-translationally regulated (Fig. 2D). Furthermore, Atp7b protein expression was suppressed by Atox1 
KD in MT-KO cells (Fig. 2F) whereas SOD1 and Atp7a protein expressions were not changed (Fig. 2E and 
2G). In summary, Atox1 KD increased Ctr1 and Ccs expression and decreased Atp7b expression in MT-KO 
cells. These observations could reflect Cu deficiency in MT-KO/Atox1 KD cells. 
 
Effects of Atox1 knockdown on Cu concentration in whole cells and distribution in cytoplasm 
Although Cu concentration in MT-WT cells showed a tendency to increase with Atox1 KD, the 
increase was not significant (Fig. 3A). On the other hand, Cu concentration in MT-KO cells was 
significantly increased by Atox1 KD (Fig. 3B). In addition, our finding that Cu concentration in MT-KO 
cells (222 ± 22 pg/1.0 x 105 cells) was lower than that in MT-WT cells (367 ± 51 pg/1.0 x 105 cells) without 
Atox1 KD coincided with a previous report14. 
Two major Cu peaks appearing at retention times of 11.6 and 13.0 min were detected in the 
chromatogram of MT-WT cells (Fig. 4A). The molecule assignable to the former peak bound both Cu and 
Zn in equal molar amounts (Fig. 2B) and its chromatographic behavior was identical to that previously 
reported19, suggesting that it could be assigned to SOD1. The molecule assignable to the latter peak also 
bound Cu and Zn but the molar ratio of Zn to Cu was considerably high (Fig. 4A and 4B). As its 
chromatographic behavior was identical to that previously reported19, this peak was assigned to MT. 
However, it was previously shown that this column was unable to separate the two major MT isoforms 
because of their highly homologous amino acid sequences, very similar molecular sizes, and metal-binding 
properties19. Although Atox1 KD did not change the mRNA expressions of both MT isoforms, i.e., MT-I 
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and MT-II (data not shown), the amount of Cu bound to MT was slightly increased by 1.37 times (Fig. 4A). 
No apparent changes in Zn distribution were noted between control and Atox1 siRNA treated cells (Fig. 
4B). 
Although the peak corresponding to SOD1 in the cytoplasm of MT-KO cells was identical to that 
of MT-WT cells, the peak corresponding to MT was lacking in the chromatogram of MT-KO cells (Fig. 4D). 
Cu was eluted at the retention time corresponding to MT; however, it was not bound to MT (no MT 
proteins are expressed in MT-KO cells) and the identity of the Cu-binding protein remains unknown (Fig. 
4C). There were no apparent changes in Cu and Zn distributions between control and Atox1 siRNA treated 
MT-KO cells (Fig. 4C and 4D). These results suggest that the increased Cu concentration in MT-KO cells 
due to Atox1 KD did not distribute to the cytoplasm, and other techniques to reveal Cu distribution are 
needed, in addition to speciation. 
 
Effects of Atox1 knockdown on Cu distribution in whole cells detected by Cu-specific fluorescent probe 
Speciation, which is conducted to analyze the distribution of Cu or other metals, is limited to the 
soluble fraction, i.e., the cytoplasm. Fluorescence imaging of Cu, which investigates intracellular Cu 
distribution in the whole cell, is a complementary technique to speciation. In this experiment, CS1 was used 
as the Cu-specific probe. Although CS1 has many advantages for Cu imaging in live cells, including 
solubility in water and a turn-on fluorescent sensor with s high Cu+ selectivity and sensitivity20, 
fluorescence bleaching is fast. Thus, we detected the fluorescence of the Cu-CS1 complex 120, 180, and 
240 s after the addition of CS1 into the cells. The fluorescence of the Cu-CS1 complex was primarily 
localized in the cytoplasm of MT-WT cells, and as expected, it was bleached in a time-dependent manner 
(Fig. 5A, 5B, and 5C). The fluorescence intensity seemed to be slightly increased by Atox1 KD in MT-WT 
cells (Fig. 5D, 5E, and 5F). This was consistent with the increasing tendency of Cu concentration with 
Atox1 KD in MT-WT cells. In MT-KO cells, the fluorescence of the Cu-CS1 complex was dominantly 
detected in the cytoplasm (Fig. 5G, 5H, and 5I) and its intensity was apparently increased by Atox1 KD 
(Fig. 5J, 5K, and 5L). Moreover, large vesicles exhibiting the fluorescence of the Cu-CS1 complex were 
observed in cells bearing a double defect in MT and Atox1, suggesting that the Cu concentration increase 
with Atox1 KD was compartmentalized in these vesicles in MT-KO cells (arrowheads in Fig. 5L). 
 
Effects of Atox1 knockdown on Ctr1 localization in cells 
As mentioned above, Atox1 KD induced Ctr1 expression at both mRNA and protein levels in 
MT-KO cells (Figs. 1F and 2B). To investigate whether the elevated Ctr1 protein was expressed in its 
primary site of localization, i.e., plasma membrane, or other sites resulting from relocalization, Ctr1 was 
stained. Consistent with previous results, Ctr1 was primarily localized on the plasma membrane of both 
MT-WT and MT-KO cells with the control siRNA treatment (Fig. 6A and 6B). The amount and localization 
of Ctr1 in MT-WT cells were not changed by Atox1 KD (Fig. 6C). On the other hand, the induction of Ctr1 
by Atox1 KD in MT-KO cells was also observed by immunocytochemistry, and the induced Ctr1 localized 
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on the plasma membrane (Fig. 6D). This result also suggests that cells bearing a double defect in MT and 
Atox1 show paradoxical response to the Cu deficiency resulting in the increase in Ctr1 expression, despite 
the fact that Cu concentration in whole cells is actually increased by Atox1 KD in MT-KO cells. 
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Discussion 
 
 
 As expected, Atox1 KD increased cellular Cu concentration. Cu bound to Atox1 is transferred to 
Atp7a or Apt7b across the Golgi membrane and is excreted into extracellular fluid mediated by the 
trans-Golgi network21,22. Thus, the manifestations of Atox1-KO mice resemble those of mice bearing a 
defect in Atp7a that resulted in a defect in Cu absorption in the intestine23. On the other hand, as Atp7b is 
specifically expressed in the liver, manifestations in the liver or cells of Atp7b- defective animals also 
resemble those of cells lacking Atox1, i.e., the accumulation of Cu in the liver or cells24. In addition, a 
defect in Commd1, which is supposed to cooperate with Atp7b in excreting Cu, results in manifestations 
resembling those of Atp7b defect. The most symptomatic manifestation of the defect in these genes, i.e., the 
increase in Cu concentration, produces several cellular responses, such as the induction of MT25-27, the 
relocalization of Ctr128 and Cu-transporting ATPases29, and the degradation of Cu chaperones30 in order to 
detoxify and normalize the elevated intracellular Cu concentration. Among the above cellular responses, the 
induction of MT is commonly and primarily detected in cells bearing a defect in Atp7a, Atp7b, Commd1 or 
Atox1. Indeed, the slight increase in Cu bound to MT was observed in MT-WT/Atox1 KD cells (Fig. 4A). 
In contrast to MT-WT cells, MT-KO cells exhibited unique responses to the elevation of intracellular Cu 
concentration by Atox1 KD. The speciation study showed that elevated Cu was not distributed in the 
cytoplasm, and elemental imaging revealed that Cu was localized in intracellular vesicles. Recently, it was 
reported that late endosomes and lysosomes act as a Cu pool for the maintenance of cellular Cu 
homeostasis in HEK-293T, HeLa, and U2OS cell lines31. Although it remains to be demonstrated that 
intracellular vesicles, i.e., late endosomes and lysosomes, contain Cu by direct methods, such as elemental 
imaging of Cu, the vesicles may be one of the candidates for explaining Cu-containing vesicles in 
MT-KO/Atox1 KD cells detected by the direct method. Based on our observations of the vesicles, we 
suppose that the vesicles isolate and detoxify elevated Cu in place of MT in MT-KO/Atox1 KD cells. Even 
in MT-WT cells, the vesicles might act when MT is not induced or the amount of elevated Cu exceeds the 
biosynthetic capacity of MT. 
 Several responses of Cu-regulating proteins to Atox1 KD were detected at mRNA and protein 
levels in MT-KO cells, i.e., increases in Ctr1 and Ccs and the decrease in Atp7b were observed. Ctr1 
functions in the high affinity uptake of Cu on the plasma membrane of various mammalian cells32-34, and is 
rapidly liberated from the plasma membrane in response to the increase in the intracellular concentration of 
Cu but not other metals35. This phenomena seem to be quite reasonable because the desorption of Ctr1, the 
high-affinity Cu influx transporter, from the plasma membrane decreases Cu incorporation. However, Ctr1 
expression was increased in both mRNA and protein levels and the elevated Ctr1 was fixed on the plasma 
membrane by Atox1 KD in MT-KO cells. These observations apparently suggest that the cells perceive the 
Cu deficiency. It has been reported that Ccs is degraded by 26S proteosome depending on the intracellular 
Cu concentration36-38. According to the literature, the amount of Cu bound to Ccs may be minimal as the 
exchange of Cu from Ccs to SOD1 is very rapid. When cellular Cu level increases, the amount of holo Ccs 
(Cu-binding Ccs) also increases. Holo Ccs more efficiently undergoes ubiquitin-mediated proteosomal 
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degradation than apo Ccs. Thus, the elevation of cellular Cu results in the decrease in Ccs protein and Ccs 
protein expression inversely reflects cellular Cu concentration. In our observations, Ccs protein expression 
was apparently increased by Atox1 KD in MT-KO cells. Taken together, cells bearing a double defect in 
MT and Atox1 also showed Cu deficiency from the results of Ccs expression. Interestingly, it was reported 
that Ccs expression was increased in intestinal epithelial cells of mice whose Ctr1 was conditionally 
knocked out despite the increase in Cu concentration in the cells39. Although the mechanisms of the 
increased Ccs expression are still unclear, the results well coincide with our observations. At present, there 
is no literature indicating that Atp7b expression is responsible for the cellular Cu concentration. However, 
as Atp7b can act as a Cu-efflux pump, it is straightforward to assume that the decrease in Atp7b expression 
is a response to the Cu deficiency. Further studies to reveal the regulation mechanisms for Atp7a and Atp7b 
expressions are needed to answer the question why Atp7a expression is not changed. Consequently, 
although cellular Cu concentration was actually increased, all responses of Cu-regulating proteins detected 
in this study suggested that cells bearing the double defect in MT and Atox1 were Cu-deficient. This 
discrepancy can be explained as follows. Elevated Cu in MT-KO/Atox1 KD cells was compartmentalized 
by vesicles to mask Cu toxicity. Elevated Cu masked by MT may be promptly used when Cu concentration 
decreases. However, in MT-KO cells, elevated Cu due to Atox1 KD was masked by vesicles; thus, the 
once-compartmentalized Cu by vesicles may not be promptly utilized by cells when Cu concentration 
decreases. In other words, Cu compartmentalized by vesicles is less bioavailable than Cu sequestered by 
MT. Hence, MT may play a suitable role in maintaining Cu homeostasis by immediately responding to Cu 
status ranging from deficiency to excess. 
 Atox1 KD in MT-KO cells apparently induced Crt1 mRNA expression. In budding yeast 
Saccharomyces cerevisiae and fruit fly Drosophila melanogaster, their Ctr1 homologues, i.e., Ctr1 and 
Ctr1B, are transcriptionally induced by Cu-dependent transcription factors, Mac1 and dMTF-1 
(metal-responsive transcription factor-1), respectively, under ambient low Cu condition40,41. In mammals, 
Ctr1 is regulated mainly at the post-translational level, such as protein degradation and/or endocytosis, 
depending on the cellular Cu concentration42,43. In addition to the post-translational regulation, it is 
suggested that the transcriptional regulation of Ctr1 gene would allow for fine tuning of cellular Cu 
concentration, although the mechanisms remain unclear44. Hence, this model, i.e., mouse fibroblasts 
bearing a double defect in MT and Atox1, may contribute to clarifying the mechanisms underlying the 
transcriptional regulation of Ctr1 in Cu deficiency. Moreover, cells have elaborated the system for Cu 
homeostasis. In particular, MT plays a bifunctional role in Cu deficiency and excess by recruiting and 
detoxifying Cu, respectively. As MT-KO cells is frail against Cu toxicity KD of Cu-regulating genes other 
than Atox1 in MT-KO cells is expected to give us new insights into Cu homeostasis. 
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Figure 1. Effects of Atox1 KD on the mRNA expression of Cu-regulating genes in MT-WT and MT-KO 
cells. MT-WT (A-D) and MT-KO (E-H) cells were pre-incubated for 24 h and the cells were treated with 
control or Atox1 siRNA at 100 nM for 24 h. After the siRNA transfection, total RNA was isolated from the 
cells. The mRNA expressions of Atox1 (A and E) and other Cu-regulating genes, such as Ctr1 (B and F), 
Cox17 (C and G), and Ccs (D and H), were quantified by RT-PCR analysis and normalized to β-actin levels. 
Atox1 expression was significantly knocked down by the siRNA treatment in MT-WT and MT-KO cells (A 
and E). Ctr1 mRNA expression was significantly increased by Atox1 KD in MT-KO cells (F). Data are 
expressed as means ± SD of three independent determinations. 
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Figure 2. Effects of Atox1 KD on the expression of Cu-regulating proteins in MT-KO cells. MT-KO cells 
were pre-incubated for 24 h and then treated with control or Atox1 siRNA at 100 nM for 24 h. After the 
siRNA transfection, cells were lysed and the supernatant for Western blotting was obtained by 
centrifugation. The protein samples (50 μg) were electrophoresed and transferred to a nitrocellulose 
membrane. After the membranes were blocked, they were incubated with antibodies against Atox1 (A), 
Ctr1 (B), Cox17 (C), Ccs (D), Atp7a (E), Atp7b (F), SOD1 (G) or β-actin (H). After the incubation with a 
secondary antibody, the blots were detected with a chemiluminescent reagent on an X-ray film. Atox1 
protein expression was also inhibited by Atox1 KD (A). Increases in Ctr1 (B) and Ccs (D) and the decrease 
in Atp7b (F) at the protein level were observed in MT-KO cells with Atox1 KD. 
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Figure 3. Cu concentration in MT-WT and MT-KO cells treated with control or Atox1 siRNA. MT-WT (A) 
and MT-KO (B) cells were pre-incubated for 24 h and then treated with control or Atox1 siRNA at 100 nM 
for 24 h. After the siRNA transfection, the harvested cells were wet-ashed with nitric acid for 24 h on a hot 
plate and then diluted with deionized water. Cu concentration in the samples was determined by an ICP-MS 
equipped with a micro flow nebulizer (PFA-20) at m/z 65. Cu concentration in MT-KO cells was 
significantly increased by Atox1 KD (B), and that in MT-WT cells showed a tendency to increase (A). Data 
are expressed as means ± SD of three independent determinations. 
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Figure 4. Elution profiles of Cu and Zn in the cytosolic fraction of MT-WT and MT-KO cells treated with 
control or Atox1 siRNA on the gel filtration column. MT-WT (A) and MT-KO (B) cells were pre-incubated 
for 24 h and the cells were treated with control or Atox1 siRNA at 100 nM for 24 h. After the siRNA 
transfection, the cells were collected and suspended to a concentration of 2.0 x 104 cells/µL with 10 mM 
Tris-HCl, pH 7.2. The suspended cells were disrupted with an ultrasonic homogenizer on ice and the 
cytosolic fraction for application to a narrow bore HPLC-ICP-MS was obtained by ultracentrifugation of 
the homogenate. The HPLC system equipped with a narrow bore multi-mode gel-filtration column (Shodex 
Protein KW802.5-2E, 2.0 mm i.d. × 250 mm) was used. A 5.0 µL aliquot of cytosol was applied to the 
column and the column was eluted with 100 mM ammonium acetate, pH 7.2, at a flow rate of 40 µL/min. 
The eluate was introduced into a micro concentric nebulizer connected to a cyclone chamber of ICP-MS. 
Cu and Zn in the eluate were monitored at m/z 65 and 66, respectively. Two major Cu peaks appearing at 
retention times of 11.6 and 13.0 min were detected in the chromatogram of MT-WT cells (A). The former 
and latter peaks correspond to SOD1 and MT, respectively. Although there were no changes in the Zn 
elution profiles between control and Atox1 siRNA treated cells (B), the amount of Cu bound to MT was 
slightly increased by the Atox1 siRNA treatment (A). There were no apparent changes in the Cu and Zn 
distributions in MT-KO cells treated with control and Atox1 siRNA (C and D). 
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Figure 5. Cu imaging in MT-WT and MT-KO cells treated with control or Atox1 siRNA. MT-WT (A-F) 
and MT-KO (G-L) cells. After the siRNA transfection, the cells were incubated with 5 µM CS1 dissolved in 
dimethyl sulfoxide for 120, 180, and 240 s at 37 °C. Then, the fluorescence of the Cu-CS1 complex in the 
cells was detected. Cu elevated by the Atox1 KD was compartmentalized in these vesicles in MT-KO cells 
(arrowheads in panel L). 
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Figure 6. Localization of Ctr1 in MT-WT and MT-KO cells treated with control or Atox1 siRNA. MT-WT 
(A and C) and MT-KO (B and D) cells were pre-incubated for 24 h and then treated with control or Atox1 
siRNA at 100 nM for 24 h. After the siRNA transfection, the cells were washed twice with PBS, fixed with 
4% formaldehyde in PBS for 30 min at room temperature, and permeabilized with 0.1% Triton X-100 for 
30 min. After blocking the fixed cells, the cells were incubated with the primary antibody against Ctr1. The 
complex of Ctr1 and its primary antibody was detected with Alexa Fluor® 488 goat anti-rabbit IgG as the 
secondary antibody. The nuclei were stained with DAPI for 10 min. Alexa Fluor® 488 and DAPI 
fluorescence was detected with a fluorescence microscope and their digital images were captured with the 
MetaMorph 7.5 system. Ctr1 was primarily localized on the plasma membrane of both MT-WT and 
MT-KO cells treated with control siRNA (A and B). Although the amount and localization of Ctr1 in 
MT-WT cells were not changed by Atox1 KD (C), Ctr1 was induced by Atox1 KD in MT-KO cells, and the 
induced Ctr1 localized on the plasma membrane (D). 
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Conclusions 
 
 
Living organisms are considered to be an accumulation of chemical reactions and to be composed 
of elements circulated through those chemical reactions. Many biomolecules are involved in the chemical 
reactions, including nucleic acids, proteins, sugars, lipids, vitamins, and hormones. These biomolecules are 
predominantly organic compounds; however, some inorganic chemicals, the so-called essential minerals in 
the form of metals and metalloids, are required for the smooth progress of the reactions. In this regard, any 
disruptions of the biochemical reactions owing to “disturbance” of essential minerals in the body would 
cause diseases. Indeed, it is known that the disturbance of essential metals and metalloids is implicated in 
many diseases, including microbial infections, cancer, AIDS, Alzheimer's disease, and Parkinson's disease, 
as well as the pathogenesis of prion. Thus, many scientists have embarked on intensive research to 
comprehend the role of metals and metalloids in biology. 
 In Chapter1, MT-isoform-specific knockdown was observed by RT-PCR and 2D micro 
HPLC-ICP-MS. The 2D micro HPLC-ICP-MS acquired a gel filtration column and an anion-exchange 
column, was an effective tool to separate MT isoforms prepared from cultured cells. Indeed, a 100-nL 
portion of cell supernatant was sufficient for injection into the column, suggesting that the minimum cell 
number required by my 2D micro HPLC-ICP-MS system was 2.0 x 103. To our knowledge, this is the first 
report of the combination of nano-speciation with the RNAi technique. The techniques shown in this study 
are expected to contribute to clarifying the physiological and/or biological roles of MT isoforms. Moreover, 
since the RNAi technique has wide applications, the combination of nano-speciation with the RNAi 
technique may open new doors in the study of metallomics. 
In Chapter 2, because of the high homology between MT-I and MT-II, Nothern and Western 
bloting techniques specifically hybridizing with MT-I and MT-II are not available. Thus, the method based 
on the PCR using isoform-specific primers is the only technique to discriminate between MT-I and MT-II 
mRNA. Particularly, real time RT-PCR is of higher quantitative than the other methods. However, as shown 
in this study, the amount of MT mRNA determined by even real time RT-PCR was not precisely coincident 
with the amount of MT bound to Cu in the kidney of the mutant mice because MT binding Cu in the kidney 
may be not induced in situ. The narrow bore HPLC-ICP-MS is applicable to a minute amount of samples 
such as neonatal and fetal tissues. Although SOD1 or MT isoforms are detected by the narrow bore 
HPLC-ICP-MS, Cu chaperones are unable to detect by current techniques due to their small amounts in 
tissue supernatant. For instance, it was reported that the amount of Ccs was one-twelfth as that of SOD1 
which was the target or partner of Ccs. At least, ten or more times sensitive higher than the current is 
required to reveal the dynamics of Cu by Cu chaperones. Therefore, the speciation of Cu performed by the 
narrow bore HPLC-ICP-MS acts as a complementary technique of the mRNA determination to reveal the 
Cu metabolism. 
In Chapter 3, intracellular Cu concentration was increased by Atox1-KD in MT-KO cells and 
elevated Cu was compartmentalized in cellular vesicles in the form of late endosomes and/or 
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lysosomes. Although intracellular Cu concentration was actually elevated, several manifestations of 
Cu deficiency appeared in the cells. These suggest that Cu compartmentalized in the vesicles may be 
less bioavailable than Cu bound to MT. Our results provide new insights into the mechanisms involved 
in the maintenance of Cu homeostasis, namely, a novel role of cellular vesicles in the detoxification of 
Cu in mammalian cells. 
Finally, I demonstrate a novel role of metallothionein, a heavy metal-binding protein, in cellular 
copper homeostasis by means of multi-disciplinary approaches, such as copper speciation and 
copper-specific imaging. As the thesiscontains topics related to the fields of biology, inorganic chemistry, 
and analytical chemistry, I expect it to be an interesting read for scientists in those fields. 
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